These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15341359)

  • 21. The use of bovine porous bone mineral in combination with enamel matrix proteins or with an autologous fibrinogen/fibronectin system in the treatment of intrabony periodontal defects in humans.
    Lekovic V; Camargo PM; Weinlaender M; Vasilic N; Djordjevic M; Kenney EB
    J Periodontol; 2001 Sep; 72(9):1157-63. PubMed ID: 11577946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical evaluation of demineralized freeze-dried bone allograft with and without enamel matrix derivative for the treatment of periodontal osseous defects in humans.
    Hoidal MJ; Grimard BA; Mills MP; Schoolfield JD; Mellonig JT; Mealey BL
    J Periodontol; 2008 Dec; 79(12):2273-80. PubMed ID: 19053917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enamel matrix proteins and guided tissue regeneration with titanium-reinforced expanded polytetrafluoroethylene membranes in the treatment of infrabony defects: a comparative controlled clinical trial.
    Zucchelli G; Bernardi F; Montebugnoli L; De SM
    J Periodontol; 2002 Jan; 73(1):3-12. PubMed ID: 11846197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A minimally invasive surgical technique with an enamel matrix derivative in the regenerative treatment of intra-bony defects: a novel approach to limit morbidity.
    Cortellini P; Tonetti MS
    J Clin Periodontol; 2007 Jan; 34(1):87-93. PubMed ID: 17243998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enamel matrix derivative and low-level laser therapy in the treatment of intra-bony defects: a randomized placebo-controlled clinical trial.
    Ozcelik O; Cenk Haytac M; Seydaoglu G
    J Clin Periodontol; 2008 Feb; 35(2):147-56. PubMed ID: 18081859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of human recession defects treated with coronally advanced flaps and either enamel matrix derivative or connective tissue. Part 1: Comparison of clinical parameters.
    McGuire MK; Nunn M
    J Periodontol; 2003 Aug; 74(8):1110-25. PubMed ID: 14514224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of intrabony periodontal defects with enamel matrix derivative: a literature review.
    Kalpidis CD; Ruben MP
    J Periodontol; 2002 Nov; 73(11):1360-76. PubMed ID: 12479642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of intrabony defects with an enamel matrix protein derivative or bioabsorbable membrane: an 8-year follow-up split-mouth study.
    Sculean A; Schwarz F; Miliauskaite A; Kiss A; Arweiler N; Becker J; Brecx M
    J Periodontol; 2006 Nov; 77(11):1879-86. PubMed ID: 17076614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The combined use of Nd:YAG laser and enamel matrix proteins in the treatment of periodontal infrabony defects.
    Dilsiz A; Canakci V; Aydin T
    J Periodontol; 2010 Oct; 81(10):1411-8. PubMed ID: 20528697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized clinical trial comparing enamel matrix derivative and membrane treatment of buccal class II furcation involvement in mandibular molars. Part II: secondary outcomes.
    Meyle J; Gonzales JR; Bödeker RH; Hoffmann T; Richter S; Heinz B; Arjomand M; Reich E; Sculean A; Jepsen K; Jepsen S
    J Periodontol; 2004 Sep; 75(9):1188-95. PubMed ID: 15515332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histologic evaluation of human intrabony defects following non-surgical periodontal therapy with and without application of an enamel matrix protein derivative.
    Sculean A; Windisch P; Keglevich T; Gera I
    J Periodontol; 2003 Feb; 74(2):153-60. PubMed ID: 12666702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective assessment of the use of enamel matrix derivative with minimally invasive surgery: 6-year results.
    Harrel SK; Wilson TG; Nunn ME
    J Periodontol; 2010 Mar; 81(3):435-41. PubMed ID: 20192871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of enamel matrix protein derivative on healing of surgical supra-infrabony periodontal defects in the rat molar: a histomorphometric study.
    Nemcovsky CE; Zahavi S; Moses O; Kebudi E; Artzi Z; Beny L; Weinreb M
    J Periodontol; 2006 Jun; 77(6):996-1002. PubMed ID: 16734574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of intrabony defects with enamel matrix proteins or barrier membranes: results from a multicenter practice-based clinical trial.
    Sanz M; Tonetti MS; Zabalegui I; Sicilia A; Blanco J; Rebelo H; Rasperini G; Merli M; Cortellini P; Suvan JE
    J Periodontol; 2004 May; 75(5):726-33. PubMed ID: 15212355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical evaluation of an enamel matrix protein derivative combined with either a natural bone mineral or beta-tricalcium phosphate.
    Döri F; Arweiler N; Gera I; Sculean A
    J Periodontol; 2005 Dec; 76(12):2236-43. PubMed ID: 16332235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of platelet-rich plasma on the healing of intrabony defects treated with an enamel matrix protein derivative and a natural bone mineral.
    Döri F; Nikolidakis D; Húszár T; Arweiler NB; Gera I; Sculean A
    J Clin Periodontol; 2008 Jan; 35(1):44-50. PubMed ID: 18034853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and histologic evaluation of non-surgical periodontal therapy with enamel matrix derivative: a report of four cases.
    Mellonig JT; Valderrama P; Gregory HJ; Cochran DL
    J Periodontol; 2009 Sep; 80(9):1534-40. PubMed ID: 19722806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term follow-up and tomographic assessment of an intrabony defect treated with enamel matrix derivative.
    Bhatavadekar NB; Paquette DW
    J Periodontol; 2008 Sep; 79(9):1802-8. PubMed ID: 18771385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Four-year results of a prospective-controlled clinical study evaluating healing of intra-bony defects following treatment with an enamel matrix protein derivative alone or combined with a bioactive glass.
    Sculean A; Pietruska M; Arweiler NB; Auschill TM; Nemcovsky C
    J Clin Periodontol; 2007 Jun; 34(6):507-13. PubMed ID: 17451415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regenerative therapy of infrabony defects with or without systemic doxycycline. A randomized placebo-controlled trial.
    Röllke L; Schacher B; Wohlfeil M; Kim TS; Kaltschmitt J; Krieger J; Krigar DM; Reitmeir P; Eickholz P
    J Clin Periodontol; 2012 May; 39(5):448-56. PubMed ID: 22385260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.